Clinical Trial Update: Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an adjuvanted hepatitis B vaccine to a double dose of Engerix-B in pre- or haemodialysis patients aged 15 and older has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• Fendrix

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED